1. Home
  2. INHD vs CTXR Comparison

INHD vs CTXR Comparison

Compare INHD & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INHD
  • CTXR
  • Stock Information
  • Founded
  • INHD 2019
  • CTXR 2007
  • Country
  • INHD United States
  • CTXR United States
  • Employees
  • INHD N/A
  • CTXR N/A
  • Industry
  • INHD
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • INHD
  • CTXR Health Care
  • Exchange
  • INHD Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • INHD 19.8M
  • CTXR 21.6M
  • IPO Year
  • INHD 2023
  • CTXR N/A
  • Fundamental
  • Price
  • INHD $1.41
  • CTXR $1.67
  • Analyst Decision
  • INHD
  • CTXR Strong Buy
  • Analyst Count
  • INHD 0
  • CTXR 3
  • Target Price
  • INHD N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • INHD 834.2K
  • CTXR 1.5M
  • Earning Date
  • INHD 08-11-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • INHD N/A
  • CTXR N/A
  • EPS Growth
  • INHD N/A
  • CTXR N/A
  • EPS
  • INHD N/A
  • CTXR N/A
  • Revenue
  • INHD $1,559,595.00
  • CTXR N/A
  • Revenue This Year
  • INHD N/A
  • CTXR N/A
  • Revenue Next Year
  • INHD N/A
  • CTXR N/A
  • P/E Ratio
  • INHD N/A
  • CTXR N/A
  • Revenue Growth
  • INHD 287.83
  • CTXR N/A
  • 52 Week Low
  • INHD $1.11
  • CTXR $0.65
  • 52 Week High
  • INHD $19.78
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • INHD 42.73
  • CTXR 56.18
  • Support Level
  • INHD $1.30
  • CTXR $1.40
  • Resistance Level
  • INHD $1.51
  • CTXR $1.67
  • Average True Range (ATR)
  • INHD 0.11
  • CTXR 0.18
  • MACD
  • INHD 0.04
  • CTXR -0.03
  • Stochastic Oscillator
  • INHD 42.25
  • CTXR 36.90

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: